
Zhejiang scientists unveil engineered immune cell therapy for heart failure
Heart failure affects more than 64 million people globally, and severe cases still carry a five-year mortality rate approaching 50% despite standard therapies.

Heart failure affects more than 64 million people globally, and severe cases still carry a five-year mortality rate approaching 50% despite standard therapies.

Its approach centers on a “software-defined aircraft” concept, drawing parallels with Tesla’s transformation of the automotive industry through software-centric design.

The blueprint, part of a broader “AI plus manufacturing” initiative, aims to build a coordinated innovation system spanning core technologies, product supply and service ecosystems.

The action plan focuses on “full-scene openness,” meaning AI will be applied across every aspect of the manufacturing process.

The initiative is part of a broader push by Zhejiang University of Technology to strengthen international partnerships and link academic research with industrial applications.